EXECUTIVE COMMITTEE

Dr. David R. Ebsworth

Dr. David R. Ebsworth

CEO Galenica Group, CEO Vifor Pharma

Dr. David R. Ebsworth

Dr. David R. Ebsworth

CEO Galenica Group, CEO Vifor Pharma

_British citizen
_BSc in Chemistry and German, PhD in Comparative Industrial Relations, University of Surrey (England),
_Worked from 1980 as a Product Manager at Pfizer, Germany, held between 1983 and 2001 various management positions at Bayer AG in Germany, Canada and the USA, became CEO of Oxford Glycosciences UK Ltd. in 2002, then held from 2003 positions as a consultant while being a member of or chairing the Board of Directors of several companies in Germany, England and Eastern Europe
_Joined the group in 2009 as a member of the Corporate Executive Committee, Head of the Pharma Division and CEO of Vifor Pharma
_Chief Executive Officer Galenica Group since 2012
_Member of the Board of Directors: Intercell AG, Austria

Dr. Gianni Zampieri

Dr. Gianni Zampieri

Deputy CEO Vifor Pharma and Head of Pharma Operations

Dr. Gianni Zampieri

Dr. Gianni Zampieri

Deputy CEO Vifor Pharma and Head of Pharma Operations

_Swiss citizen
_PhD ETH Zurich (Federal Institute of Technology), postgraduate study economics, Senior Executive Program, Standford University, USA
_Held positions with Hofmann-La Roche and Novartis (Strategic Planning)
_Joined the Group in 1996 as CEO Vifor (International) Ltd., then became Head of the Pharma Division, Galenica Group; since 2002 Member of the Corporate Executive Committee, since 2008 Head of Industrial Operations with Vifor Pharma, St. Gallen and in 2010 CEO of OM Pharma, 2011 Deputy CEO of Vifor Pharma
_Head of Pharma Operations since 2012


Beatrix Benz

Beatrix Benz

Head of Global Communications

Beatrix Benz

Beatrix Benz

Head of Global Communications

_Swiss citizen
_Bachelors of Arts, Communications and Journalism, Institute for Applied Media Science, University of Applied Science, Zurich
_Leading positions such as Head of Communications Europe & Asia-Pacific with Novartis Animal Health, Director Global Media Relations and Global Spokesperson with Novartis International AG and Associate Director External Communications and Global Spokesperson with Nycomed International
_Joined the Group as Head of Global Communications Vifor Pharma in 2011

Dr. Maureen Lisa Cronin

Dr. Maureen Lisa Cronin

Global Head Medical Affairs

Dr. Maureen Lisa Cronin

Dr. Maureen Lisa Cronin

Global Head Medical Affairs

_Born in USA, German citizen
_BA University of Minnesota; MD, Free University, Berlin Germany; PhD in Medicine, Friedrich-Schiller University Jena, Germany
_Clinical training as physician in Internal Medicine; with Schering AG (today’s Bayer Schering Pharma AG) from 1998 to 2010 in roles of increasing responsibility, most recently as VP and Head Global Medical Affairs Women’s Healthcare
_Joined the group in 2010 as Global Head Medical Affairs Vifor Pharma


Charles R. DeLoach

Charles R. DeLoach

CEO Vifor Fresenius Medical Care Renal Pharma

Charles R. DeLoach

Charles R. DeLoach

CEO Vifor Fresenius Medical Care Renal Pharma

_American citizen
_Masters, Business Administration – Northern Illinois University, United States, BS, Business Administration – Louisiana Tech University, United States
_Leading positions such as Manager Field Coach Development with Lederle Labs, USA, Area Business Director with Wyeth, USA, Vice President, Sales and Marketing Boca Raton with Nabi Biopharmaceuticals, USA and Vice President, Renal Pharmaceuticals, Fresenius Medical Care, USA
_Joined the Group as CEO, Vifor Fresenius Medical CareRenal Pharmaceutical, member of the Vifor Pharma leadership team in 2011

Dr. Behruz S. Eslami

Dr. Behruz S. Eslami

Global Head of Regulatory Affairs

Dr. Behruz S. Eslami

Dr. Behruz S. Eslami

Global Head of Regulatory Affairs

_American citizen
_PhD in Molecular Biology, New York Medical College, New York, USA, Bachelor of Science in Chemistry, Southern Connecticut State University, New Haven, USA
_Leading positions such as Regulatory Affairs Director with ARES-SERONO International, Geneva, Switzerland, Group Vice President Regulatory Affairs Europe, with Genzyme Europe, Naarden, The Netherlands
_Joined the Group as Global Head of Regulatory Affairs Vifor Pharma in 2010


Charles F. (Rick) Goulburn

Charles F. (Rick) Goulburn

Global Head of Marketing & North America

Charles F. (Rick) Goulburn

Charles F. (Rick) Goulburn

Global Head of Marketing & North America

_American citizen
_Master in Business Administration, The Wharton School, University of Pennsylvania, USA, Bachelor of Science – Corporate Finance and Accouting, University of Vermont, USA
_Held different leading positions with Warner-Lambert Consumer Healthcare / Parke-Davis Pharmaceuticals in the US and Europe before moving on to Merck & Company in 2000 in the US. With Aspreva Pharmaceuticals from 2004 to 2008 as US General Manager, Global Head – Product Management, and Executive Vice President, Global Operations
_Joined the Group in 2008 as Global Head of Autoimmune Therapy Area Marketing & North America

Dr. Sanjay Jariwala

Dr. Sanjay Jariwala

Head Global Business, Commercial Development and Licensing

Dr. Sanjay Jariwala

Dr. Sanjay Jariwala

Head Global Business, Commercial Development and Licensing

_ MBBCh, University of Cambridge Medical School, England, MA Medical Sciences, University of Cambridge, England
_Leading positions such as Medical Team Leader with GSK UK, Director, Head of European Development, CV with GSK Europe, Medical Director, CV/Metabolic with GSK Europe, Executive Director, Global Business Development with Aspreva
_Joined the Group as Vice President, Global Business Development Vifor Pharma in 2009
_Head Global Business Development and Licensing in 2011
_Head Global Business, Commercial Development and Licensing since 2012



Dr. Thomas Kaspar

Dr. Thomas Kaspar

Global Head Quality Management

Dr. Thomas Kaspar

Dr. Thomas Kaspar

Global Head Quality Management

_Swiss citizen
_Dr. Sc. Nat. ETHZ; Diploma in Economics at the Fachhochschule Nordwestschweiz
_Worked at Streuli Pharma AG in the position of Head Quality Control Microbiology from 1996 - 2000
_Joined the group in 2000 and worked in different positions before taking on his role as Global Head Quality Management Vifor Pharma in 2011

Dr. Oliver P. Kronenberg

Dr. Oliver P. Kronenberg

Chief of Staff and General Counsel

Dr. Oliver P. Kronenberg

Dr. Oliver P. Kronenberg

Chief of Staff and General Counsel

_Swiss citizen
_PhD in Law at the University of Basel; College of Europe, Bruges (Belgium), LL.M.; Fordham School of Law, New York (USA), Visiting Scholar; Admitted to the Swiss Bar
_Associate at Sutter Attorneys-at-law in Zurich and Legal Counsel at ISL Worldwide in Zug. 2001 - 2004 he held several positions at the Fédération International de Football Association (FIFA) in Zurich, most recently as Head of General Legal. Corporate Counsel in Copenhagen at Ferring Pharmaceutical A/S. Returned to Zurich as Head of Legal at Kuros Biosurgery AG.
_Joined the group in 2008 as Head of Legal & Compliance and took on the role of General Counsel Vifor Pharma in 2011


Ruth Schmutz

Ruth Schmutz

Global Head Human Resources

Ruth Schmutz

Ruth Schmutz

Global Head Human Resources

_Swiss citizen
_lic.phil I, Literature and Linguistics at University of Basel, Geneva and Frankfurt, Master Advanced Studies Human Resources Management (FHNW)
_Several positions as Head Human Resources for Swiss Bank Corporation (today UBS), Coopers & Lybrand, PricewaterhouseCoopers, Vitra Group
_Joined the Group in 2006 as Head Human Resources Galenica Group, Global Head Human Resources Vifor Pharma since 2008

Dr. Dirk Schrader

Dr. Dirk Schrader

Head of Industrial Operations

Dr. Dirk Schrader

Dr. Dirk Schrader

Head of Industrial Operations

_German citizen
_PhD in Pharmaceutical Technology, WWU Muenster, Germany, Pharmaceutical Approbation, Technical University Braunschweig, Germany
_Worked from 1992-2005 in various technical and commercial positions at Bayer, as head of a production unit in Germany, Head of Technical Operations in China, Senior Vice President International Technical Operations, General Manager for the Healthcare Businesses in Taiwan and as Head of the Diagnostics/Diabetes Care business based in Switzerland.
_Then moved to Singapore as VP Operations & Supply Asia Pacific/Japan for Bristol-Myers Squibb and in 2007 changed to AstraZeneca, first as VP Supply Asia Pacific/Japan in Singapore and from 2010 as VP Lean Operations in the UK.
_Joined the Group as Head of Industrial Operations Vifor Pharma in 2012


Alex Sigalas

Alex Sigalas

Head of Finance

Alex Sigalas

Alex Sigalas

Head of Finance

_Swiss citizen
_lic. oec. HSG, specialty finance and cost accounting, University of St. Gallen; Swiss CPA External Auditor with PricewaterhouseCoopers, Controller with Accenture & Société Générale Private Banking, Internal Audit Manager with Actelion & Syngenta, Finance Director Headquarters with Actelion
_Joined the Group in 2009 as Head of Finance Vifor Pharma

Dr. Christoph Springer

Dr. Christoph Springer

Deputy CEO Vifor Fresenius Medical Care Renal Pharma

Dr. Christoph Springer

Dr. Christoph Springer

Deputy CEO Vifor Fresenius Medical Care Renal Pharma

_Swiss citizen
_Master of Natural Science at the Swiss Federal Institute of Technology (ETH) Zurich, PhD in Molecular Biology at Georg-August-University, Göttingen, MBA studies at George Washington University, Washington DC
_Global Product Leader Anaemia, with Vifor (International) Ltd., then General Manager and International Marketing Director Anaemia with AMGEN Switzerland AG
_Joined the Group in 2007 as Global Head of Anaemia TA Marketing, Vifor Pharma
_Since 2011 Deputy CEO Vifor Fresenius Medical Care Renal Pharma


Frits van Alphen

Frits van Alphen

Chief Medical Officer

Frits van Alphen

Frits van Alphen

Chief Medical Officer

_Dutch citizen
_Medical Degree – Leiden University, The Netherlands
_Clinical Research Manager, Yamanouchi Europe, The Netherlands, then held different leading roles with increasing responsibilities with Novartis from 2000 to 2008 most recently as Head Medical Affairs Region Europe, Novartis Switzerland
_Joined the Group 2008 as Chief Medical Officer

Thierry Volle

Thierry Volle

Head of International Business Operations

Thierry Volle

Thierry Volle

Head of International Business Operations

_French citizen
Institut Supérieur de Gestion, international cycle
_Master degree in Computer Science Centrale, Paris, INSEAD Program for young Managers
_Several leading positions with Wyeth-Ayerst in France, Czech Republic, USA and Switzerland
_Joined the Group in 2006 as CEO of Vifor Ltd.


Philippe Weigerstorfer

Philippe Weigerstorfer

Head of Asia Pac

Philippe Weigerstorfer

Philippe Weigerstorfer

Head of Asia Pac

_Swiss citizen
_lic. rer. pol., University of Basel
_Leading positions with Sandoz Pharma Ltd., Basel, and Novartis Pharma Ltd., Basel from 1995 to 1999
_Joined the Group in 1999 as Head of Business Development & Licensing, Member of the Corporate Executive Committee 2000-2011, Head of the Corporate Development Division 2005-2011
_Since 2011 Head of Asia Pac, Vifor Pharma



Send link

Send as link



Links

  •